Fanjun Cheng

544 total citations
25 papers, 241 citations indexed

About

Fanjun Cheng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Fanjun Cheng has authored 25 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Fanjun Cheng's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). Fanjun Cheng is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). Fanjun Cheng collaborates with scholars based in China, United States and Australia. Fanjun Cheng's co-authors include Wen Liu, Qiao Li, Alfred E. Chang, Fangzhou Xu, Hongyu Zhang, Max S. Wicha, Dongfeng Li, Xin Chen, Hanqin Wang and Jie Tang and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Cellular Physiology and Clinica Chimica Acta.

In The Last Decade

Fanjun Cheng

25 papers receiving 240 citations

Peers

Fanjun Cheng
D. Joseph United States
Amy P. Moore United States
Anja Schmid Switzerland
Robert J. Van Gulick United States
Rajeswaran Mani United States
Aung Naing United States
Ben P. Martin Australia
Fanjun Cheng
Citations per year, relative to Fanjun Cheng Fanjun Cheng (= 1×) peers Marta Siernicka

Countries citing papers authored by Fanjun Cheng

Since Specialization
Citations

This map shows the geographic impact of Fanjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanjun Cheng more than expected).

Fields of papers citing papers by Fanjun Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanjun Cheng. The network helps show where Fanjun Cheng may publish in the future.

Co-authorship network of co-authors of Fanjun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fanjun Cheng. A scholar is included among the top collaborators of Fanjun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanjun Cheng. Fanjun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Zheng, Shan Zhang, Alfred E. Chang, et al.. (2025). Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy. International Journal of Biological Sciences. 21(4). 1819–1836. 2 indexed citations
2.
Zhang, Shan, et al.. (2024). The Emerging Role of Schwann Cells in the Tumor Immune Microenvironment and Its Potential Clinical Application. International Journal of Molecular Sciences. 25(24). 13722–13722. 6 indexed citations
3.
Zhang, Haiqiang, Fang Zheng, Yan Zhang, et al.. (2024). Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms. BMC Medical Genomics. 17(1). 243–243. 2 indexed citations
4.
Cheng, Fanjun, et al.. (2023). Bioinformatic-based genetic characterizations of neural regulation in skin cutaneous melanoma. Frontiers in Oncology. 13. 1166373–1166373. 3 indexed citations
5.
Liu, Yuxin, et al.. (2023). Factors associated with the incidence and the expenditure of self-medication among middle-aged and older adults in China: A cross-sectional study. Frontiers in Public Health. 11. 1120101–1120101. 2 indexed citations
6.
Zhang, Haiqiang, Xinxin Wang, Wei Chen, et al.. (2023). Heat inactivation does not alter host plasma cell-free DNA characteristics in infectious disease research. Clinica Chimica Acta. 553. 117751–117751. 2 indexed citations
7.
Li, Zhen, et al.. (2022). Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-β1 in epithelial-to-mesenchymal transition in melanoma. Translational Cancer Research. 11(10). 3698–3710. 7 indexed citations
8.
Liu, Panhong, Mingyan Fang, Fang Zheng, et al.. (2022). Rare Variants in Inborn Errors of Immunity Genes Associated With Covid-19 Severity. Frontiers in Cellular and Infection Microbiology. 12. 888582–888582. 5 indexed citations
9.
Feng, Jing, Zihui Lei, Shijiao Yan, et al.. (2022). Prevalence and associated factors for workplace violence among general practitioners in China: a national cross-sectional study. Human Resources for Health. 20(1). 42–42. 7 indexed citations
10.
Chen, Yilin, Zelin Liu, Meng Li, et al.. (2022). Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China. Haematologica. 107(8). 1966–1970. 4 indexed citations
11.
Cheng, Fanjun, et al.. (2022). Stem cell like memory T cells: A new paradigm in cancer immunotherapy. Clinical Immunology. 241. 109078–109078. 22 indexed citations
12.
Zheng, Fang, et al.. (2022). The function of myeloid-derived suppressor cells in COVID-19 lymphopenia. International Immunopharmacology. 112. 109277–109277. 5 indexed citations
13.
Liu, Wen & Fanjun Cheng. (2021). Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p/miR-196b-5p/p27 axis. Bioengineered. 12(1). 7704–7713. 23 indexed citations
14.
Zhou, Shu, Weiming Li, Yi Xiao, et al.. (2020). A novel chimeric antigen receptor redirecting T-cell specificity towards CD26+ cancer cells. Leukemia. 35(1). 119–129. 21 indexed citations
15.
Shen, Na, Jiang Lin, Qing Li, et al.. (2017). The epigenetic effect of microRNA in BCR-ABL1-positive microvesicles during the transformation of normal hematopoietic transplants. Oncology Reports. 38(5). 3278–3284. 3 indexed citations
16.
Zheng, Fang, et al.. (2017). PD-L1 Promotes Self-Renewal and Tumorigenicity of Malignant Melanoma Initiating Cells. BioMed Research International. 2017. 1–8. 13 indexed citations
17.
Zhang, Peng, Hanqin Wang, Xinwen Min, et al.. (2009). Pim‐3 is expressed in endothelial cells and promotes vascular tube formation. Journal of Cellular Physiology. 220(1). 82–90. 29 indexed citations
18.
Zheng, Fang, et al.. (2009). The Primary Study of CD90+CD34and Sca-1+Stem Cells Mobilized by EPO Plus G-CSF in Mice. International Journal of Stem Cells. 2(2). 129–134. 4 indexed citations
19.
Chen, Qinhua, et al.. (2009). Nonaqueous CE for Rapid and Sensitive Determination of Matrine and Oxymatrine in Sophora flavescens and Its Medicinal Preparations. Chromatographia. 69(11-12). 1443–1446. 12 indexed citations
20.
Cheng, Fanjun, et al.. (2008). Study on the mechanism of apoptosis of myelocytic leukemia cell lines induced by curcumin. The Chinese-German Journal of Clinical Oncology. 7(2). 111–114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026